Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)

NCT03704610 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Extrathoracic Sarcoidosis

Interventions

DRUG: Infliximab
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris